Literature DB >> 16714363

Activated neutrophil-mediated sickle red blood cell adhesion to lung vascular endothelium: role of phosphatidylserine-exposed sickle red blood cells.

Johnson Haynes1, Boniface Obiako, Judy A King, Raymond B Hester, Solomon Ofori-Acquah.   

Abstract

Activated neutrophils (ANs) increase sickle red blood cell (SRBC) retention/adhesion in the pulmonary circulation. This study investigates the role of neutrophil activation and SRBC retention/adhesion in the pulmonary circulation through a mechanism that involves increasing phosphatidylserine (PS) exposure on the external membrane surface of the SRBCs (PS-exposed). With the use of flow cytometry, double-labeling studies were performed with a calcium-dependent phospholipid-binding protein, annexin V-fluorescein isothiocyanate fluorescence, and the erythroid-specific marker glycophorin A to assess for the percentage of PS-exposed normal and SRBCs at baseline and after coincubation with ANs. Additional studies were performed that assessed retention/adhesion of SRBCs in the isolated rat lung using (51)Cr-labeled SRBC alone, SRBC + AN, SRBC + AN + zileuton, and SRBC + AN + annexin V. Specific activities of lung and perfusate were measured, and the number of retained SRBCs per gram lung was calculated. Flow cytometry demonstrated that ANs increased the percentage of PS-exposed normal and SRBCs. The 5-lipoxygenase inhibitor zileuton attenuated AN-mediated increases in PS-exposed SRBCs and decreased SRBC retention/adherence in the lung on histological sections. Similarly, in the isolated perfused lung and in histological lung sections, retention/adherence of SRBCs cloaked with annexin V was attenuated in the presence of ANs. We conclude that ANs enhance the adhesion of SRBCs to vascular endothelium by increasing red blood cell membrane externalization of PS. Zileuton attenuation of AN-mediated SRBC PS externalization suggests that a 5-lipoxygenase product(s), secreted by the AN, plays a vital role in altering the adhesive properties of PS-exposed SRBCs to vascular endothelium.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714363     DOI: 10.1152/ajpheart.00256.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  15 in total

Review 1.  Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease.

Authors:  Marilyn J Telen
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

2.  Developing new pharmacotherapeutic approaches to treating sickle-cell disease.

Authors:  Marilyn J Telen
Journal:  ISBT Sci Ser       Date:  2016-11-15

3.  Inhaled steroids reduce pain and sVCAM levels in individuals with sickle cell disease: A triple-blind, randomized trial.

Authors:  Jeffrey Glassberg; Caterina Minnitti; Caroline Cromwell; Lawrence Cytryn; Thomas Kraus; Gwen S Skloot; Jason T Connor; Adeeb H Rahman; William J Meurer
Journal:  Am J Hematol       Date:  2017-06-05       Impact factor: 10.047

Review 4.  Pleiotropic effects of intravascular haemolysis on vascular homeostasis.

Authors:  Gregory J Kato; James G Taylor
Journal:  Br J Haematol       Date:  2009-12-01       Impact factor: 6.998

5.  Biomechanical aspects of the auto-digestion theory.

Authors:  Geert W Schmid-Schönbein
Journal:  Mol Cell Biomech       Date:  2008-06

Review 6.  Inflammatory targets of therapy in sickle cell disease.

Authors:  Amma Owusu-Ansah; Chibueze A Ihunnah; Aisha L Walker; Solomon F Ofori-Acquah
Journal:  Transl Res       Date:  2015-07-11       Impact factor: 7.012

7.  Nucleosomes and neutrophil activation in sickle cell disease painful crisis.

Authors:  Marein Schimmel; Erfan Nur; Bart J Biemond; Gerard J van Mierlo; Shabnam Solati; Dees P Brandjes; Hans-Martin Otten; John-John Schnog; Sacha Zeerleder
Journal:  Haematologica       Date:  2013-08-02       Impact factor: 9.941

8.  Advances in new drug therapies for the management of sickle cell disease.

Authors:  Kenneth I Ataga; Payal C Desai
Journal:  Expert Opin Orphan Drugs       Date:  2018-05-14       Impact factor: 0.694

Review 9.  The role of 5-lipoxygenase in the pathophysiology of COVID-19 and its therapeutic implications.

Authors:  Nohora Cristina Ayola-Serrano; Namrata Roy; Zareena Fathah; Mohammed Moustapha Anwar; Bivek Singh; Nour Ammar; Ranjit Sah; Areej Elba; Rawan Sobhi Utt; Samuel Pecho-Silva; Alfonso J Rodriguez-Morales; Kuldeep Dhama; Sadeq Quraishi
Journal:  Inflamm Res       Date:  2021-06-04       Impact factor: 6.986

10.  Asthma in sickle cell disease: implications for treatment.

Authors:  Kathryn Blake; John Lima
Journal:  Anemia       Date:  2011-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.